Feilong Zhao

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial

Wenwen Zhang, Shuang Tong, Bingyang Hu et al. · Journal for ImmunoTherapy of Cancer · 2023 · 109 citations · Full text

Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer

Yuezong Bai, Tong Xie, Zhenghang Wang et al. · Journal for ImmunoTherapy of Cancer · 2022 · 97 citations · Full text

Self-assembled anodization of NiTi alloys for biomedical applications

Ruiqiang Hang, Feilong Zhao, Xiaohong Yao et al. · Applied Surface Science · 2020 · 88 citations

Materials Science, Engineering, Self-assembly +6

Balancing the Anti‐Bacterial and Pro‐Osteogenic Properties of Ti‐Based Implants by Partial Conversion of ZnO Nanorods into Hybrid Zinc Phosphate Nanostructures

Feilong Zhao, Ang Gao, Qing Liao et al. · Advanced Functional Materials · 2024 · 86 citations

Engineering, Biomimetic Materials, Bone Repair +16

ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts

Fangli Jiang, Keren Jia, Yang Chen et al. · Advanced Science · 2023 · 38 citations · Full text